ClinicalTrials.govpublic full text
Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia
acute myeloid leukemia with t(9;11)(p22.3;q23.3); mllt3-kmt2a, fibroblast growth factor basic form measurement, flt3 internal tandem duplication, recurrent adult acute myeloid leukemia, refractory acute myeloid leukemia, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 892249
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.